Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-6,697
Closed -$203K 435
2023
Q2
$203K Buy
+6,697
New +$196K 0.02% 407
2023
Q1
Sell
-62,153
Closed -$2.33M 386
2022
Q4
$2.33M Hold
62,153
0.3% 67
2022
Q3
$2.33M Sell
62,153
-621
-1% -$24.6K 0.29% 67
2022
Q2
$2.26M Sell
62,774
-769
-1% -$31.8K 0.27% 63
2022
Q1
$3.11M Sell
63,543
-235
-0.4% -$11.9K 0.3% 57
2021
Q4
$3.05M Buy
+63,778
New +$3.02M 0.29% 55
2021
Q3
Sell
-62,478
Closed -$2.74M 385
2021
Q2
$2.74M Buy
62,478
+483
+0.8% +$22.7K 0.28% 64
2021
Q1
$2.84M Buy
+61,995
New +$2.6M 0.29% 67

Other funds holding SNV

Wintrust Investments's SNV Position: Q3 2023 in Review

Wintrust Investments sold out of Synovus (SNV) in Q3 2023, closing a stake of 6,697 shares — an estimated $203K sold.

Wintrust Investments first reported a position in SNV in Q1 2021 and held it in 8 quarters. The position peaked at $3.11M in Q1 2022. 372 funds tracked by Wall St. Rank hold SNV as of Q3 2023.

  • Wintrust Investments reported no remaining Synovus position as of Q3 2023 after selling out during the quarter.
  • Wintrust Investments sold 6,697 Synovus shares in Q3 2023, an estimated $203K.
  • Wintrust Investments first reported a position in Synovus in Q1 2021 and held it in 8 quarters.
  • Wintrust Investments's Synovus position peaked at $3.11M in Q1 2022.
  • 372 funds tracked by Wall St. Rank held Synovus as of Q3 2023.

Based on Wintrust Investments's 13F filing for Q3 2023, filed 13 Nov 2023.